Mascha Binder

Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial

Andrés J.M. Ferreri, Kate Cwynarski, Elisa Jacobsen Pulczynski et al. · The Lancet Haematology · 2016 · 599 citations · Full text

Medicine, Immunology, Oncology +12

The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19

Christoph Schultheiß, Edith Willscher, Lisa Paschold et al. · Cell Reports Medicine · 2022 · 425 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial

Andrés J.M. Ferreri, Kate Cwynarski, Elisa Jacobsen Pulczynski et al. · The Lancet Haematology · 2017 · 381 citations · Full text

Medicine, Immunology, Oncology +17

Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation

Mary Hongying Cheng, She Zhang, Rebecca A. Porritt et al. · Proceedings of the National Academy of Sciences · 2020 · 360 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Resistance to anti-CD19/CD3 BiTE in acute lymphoblastic leukemia may be mediated by disrupted CD19 membrane trafficking

Friederike Braig, Anna Brandt, Mariele Goebeler et al. · Blood · 2016 · 261 citations

Life Sciences, Immunology, Oncology +16